Skip to content
zynerba logo
  • Investors
    • IR Information
    • Stock Information
    • Press Releases
    • Events & Webcasts
    • Presentations
    • Enhanced SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • IRS Form 8937
    • Investor Contacts
  • News
    • Press Releases
    • Events
  • Publications
    • Manuscripts and Presentations
  • Careers
  • LinkedIn
  • Twitter
  • Our Focus
    • Why Rare?
    • Why Neuropsychiatric Disorders?
    • Why Cannabinoids?
    • Why pharmaceutical manufacturing?
  • Our Pipeline
    • ZygelTM
    • Early Access to Medicine
  • Clinical Trials
  • Our Team
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Patient Resources
    • FXS
    • ASD
    • 22q

Zynerba Press Releases

6 Jan 16 Zynerba Pharmaceuticals Announces Positive Initial Results From ZYN002 CBD Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1 Multiple Rising Dose Trial

24 Nov 15 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

16 Nov 15 Zynerba Pharmaceuticals Appoints Warren D. Cooper Lead Independent Director

11 Nov 15 Zynerba Pharmaceuticals Reports Third Quarter 2015 Financial Results and Operational Highlights

11 Nov 15 Zynerba Pharmaceuticals to Present at Jefferies Autumn 2015 Global Healthcare Conference

20 Oct 15 Zynerba Pharmaceuticals Initiates Phase 1 Clinical Trial for ZYN002 CBD Gel

7 Oct 15 Zynerba Pharmaceuticals to Present at BIO Investor Forum 2015

10 Aug 15 Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares

6 Aug 15 Zynerba Pharmaceuticals Builds Out Board of Directors

4 Aug 15 Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering

Page 19 of 20 | « First‹ Previous15 16 17 18 19 20 Next ›

    This site uses cookies to give you a better browsing experience. By continuing to use this website, you accept our use of these cookies. For more information, see our Privacy Notice.

    • Privacy Policy
    • Terms of Use
    • Cookie Notice
    • Accessibility Statement
    • Contact Us

    © 2022 Zynerba Pharmaceuticals, Inc. All rights reserved.

    zynerba inverted logo

    80 W. Lancaster Avenue, Suite 300
    Devon, PA 19333
    484.581.7505